Skip to main content

Advertisement

SpringerLink
Log in

Genetic Profiles in Ischaemic Stroke

  • Cardiovascular Disease and Stroke (D Leifer and JE Safdieh, Section Editors)
  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

Stroke represents a clinical syndrome rather than a single disease. A number of stroke subtypes can be distinguished based on careful phenotyping, with each of these having distinct and overlapping risk factor profiles. Recent evidence has suggested that genetics plays an important part in stroke risk, with at least 2 genes specific to stroke risk directly now having been identified. This review will explore our current understanding of the genetics underlying stroke risk and whether this information is currently useful in a clinical setting for patient benefit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Roger V, Go A, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation. 2012;125:e2–220.

    Article  PubMed  Google Scholar 

  2. Seshadri S, Beiser A, Kelly-Hayes M, Kase C, Au R, Kammel W, et al. The lifetime risk of stroke: estimates from the Framingham study. Stroke. 2006;37:345–50.

    Article  PubMed  Google Scholar 

  3. Viswanathan A, Rocca WA, Tzourio C. Vascular risk factors and dementia: how to move forward? Neurology. 2009;72:368–74.

    Article  PubMed  Google Scholar 

  4. Zhang J, Claterbuck RE. Molecular genetics of human intracranial aneurysms. Int J Stroke. 2008;3:272–87.

    Article  PubMed  Google Scholar 

  5. Sacco R, Ellenberg J, Mohr J, Tatemichi T, Hier D, Price T, et al. Infarcts of undetermined cause: the NINDS stroke data bank. Ann Neurol. 1989;25:382–90.

    Article  PubMed  CAS  Google Scholar 

  6. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383:707–10.

    Article  PubMed  CAS  Google Scholar 

  7. Hassan A, Markus HS. Genetics and ischaemic stroke. Brain. 2000;123:1784–812.

    Article  PubMed  Google Scholar 

  8. Flossmann E, Schulz U, Rothwell P. Systematic review of methods and results of studies of the genetic epidemiology of ischaemic stroke. Stroke. 2004;35:212–27.

    Article  PubMed  Google Scholar 

  9. Jerrard-Dunne P, Cloud G, Hassan A, Markus HS. Evaluating the genetic component of ischaemic stroke subtypes - a family history study. Stroke. 2003;34:1364–9.

    Article  PubMed  Google Scholar 

  10. Duggirala R, Gonzalez Villalpando C, O'Leary DH, Stern MP, Blangero J. Genetic basis of variation in carotid artery wall thickness. Stroke. 1996;27(5):833–7.

    Article  PubMed  CAS  Google Scholar 

  11. Jartti L, Ronnemaa T, Kaprio J, Jarvisalo MJ, Toikka JO, Marniemi J, et al. Population-based twin study of the effects of migration from Finland to Sweeden on endothelial functrion and intima-media thickness. Arterioscler Thromb Vasc Biol. 2002;22(5):832–7.

    Article  PubMed  CAS  Google Scholar 

  12. Moskau S, Golla A, Grothe C, Boes M, Pohl C, Klockgether T. Heritability of carotid artery atherosclerotic lesions. Stroke. 2005;36:5–8.

    Article  PubMed  Google Scholar 

  13. Carmelli D, DeCarli C, Swan G, Jack L, Reed T, Wolf P, et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke. 1998;29:1177–81.

    Article  PubMed  CAS  Google Scholar 

  14. Atwood L, Wolf P, Heard-Costa N, Massaro J, Beiser A, D'Agostino R, et al. Genetic variation in white matter hyperintensity volume in the Framingham study. Stroke. 2004;35:1609–13.

    Article  PubMed  Google Scholar 

  15. Turner S, Fornage M, Jack C, Mosley T, Knopman D, Kardia S, et al. Genomic susceptibility loci for brain atrophy, ventricular volume and leukoaraiosis in hypertensive sibships. Arch Neurol. 2009;66:847–57.

    Article  PubMed  Google Scholar 

  16. Markus HS. Unravelling hte genetics if ischaemic stroke. PLoS Med. 2010;7:e1000225.

    Article  PubMed  Google Scholar 

  17. Dichgans M, Markus HS. Genetic association studies in stroke: methodological issues and proposed standard criteria. Stroke. 2005;36:2027–31.

    Article  PubMed  Google Scholar 

  18. Martini SRFM, Brown WM, Haverbusch M, Comeau ME, Sauerbeck LR, Kissela BM, et al. Risk factors for intracerebral hemorrhage differ according to hemorrhage location. Neurology. 2012;79:2275–82.

    Article  PubMed  Google Scholar 

  19. Edwards A, Ritter R, Abel K, Manning A, Panhuysen C, Farrer L. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308:421–4.

    Article  PubMed  CAS  Google Scholar 

  20. Hardy J, Singleton A. Genomewide association studies and human disease. N Eng J Med. 2009;360:1759–68.

    Article  CAS  Google Scholar 

  21. Schunkert H, Gotz A, Braund P, McGinnis R, Tregouet D-A, Mangino M, et al. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation. 2008;117:1675–84.

    Article  PubMed  Google Scholar 

  22. Gudbjartsson D, Arnar D, Helgadottir A, Gretarsdottir S, Holm H, Sigurdsson A, et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature. 2007;448(353):358.

    Google Scholar 

  23. Gudbjartsson D, Holm H, Gretarsdottir S, Thorleifsson G, Walters G, Thorgeirsson G, et al. A sequence variant in ZFHX3 on 16q22 associates with arterial fibrillation and ischaemic stroke. Nat Genet. 2009;41:876–8.

    Article  PubMed  CAS  Google Scholar 

  24. Gschwendtner A, Bevan S, Cole J, Plourde A, Matarin M, Ross-Adams H, et al. Sequence variants on Chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann Neurol. 2009;65:531–9.

    Article  PubMed  CAS  Google Scholar 

  25. Gretarsdottir S, Thorleifsson G, Manolescu A, Styrkarsdottir U, Helgadottir A, Gschwendtner A, et al. Risk variants for atrial fibrillation on chromosome 4q25 associate with ischaemic stroke. Ann Neurol. 2008;64:402–9.

    Article  PubMed  Google Scholar 

  26. Matarin M, Brown W, Scholz S, Simon-Sanchez J, Fung H-C, Hernandez D, et al. A genome wide genotyping study in patients with ischaemic stroke: initial analysis and data release. Lancet Neurol. 2007;6:414–20.

    Article  PubMed  CAS  Google Scholar 

  27. Ikram A, Seshadri S, Bis J, Fornage M, DeStefano A, Aulchenko Y, et al. Genomewide association studies of stroke. N Eng J Med. 2009;360:1718–28.

    Article  CAS  Google Scholar 

  28. International Stroke Genetic Consortium and Wellcome Trust Case Control Consortium 2. Failure to validate association between 12p13 variants and ischaemic stroke. N Eng J Med. 2010;362:1547–50.

    Article  Google Scholar 

  29. •• Bellenguez C, Bevan S, Gschwendtnew A, Spencer C, Burgess AI, Pirinen M, et al. Genetic analysis identifies a new susceptibility locus in HDAC9 for large vessel ischemic stroke, and supports genetic heterogeneity across stroke subtypes. Nat Genet. 2012;44:328–33. First use of GWAS to identify genetic predisposition to ischaemic stroke showing successful and robust replication.

    Article  PubMed  CAS  Google Scholar 

  30. Markus HS, Makela K-M, Bevan S, Raitoharju E, Oksala N, Bis JC, et al. Evidence HDAC9 genetic variant associated with ischaemic stroke increases risk via promoting carotid atherosclerosis. Stroke 2013;In Press.

  31. Bowes AJ, Khan MI, Shi Y, Robertson L, Werstuck GH. Valproate attenuates accelerated atherosclerosis in hyperglycemic ApoE deficient mice: Evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic stenosis. Am J Pathol. 2009;174:330–42.

    Article  PubMed  CAS  Google Scholar 

  32. Olesen JB, Abildstrom SZ, Erdal J, Gislason GH, Weeke P, Andersson C, et al. Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke and death in patients with or withour previous stroke: a nationwide cohort study. Pharmacoepidemiol Drug Saf. 2011;20:964–71.

    Article  PubMed  CAS  Google Scholar 

  33. • Holliday EG, Maguire J, Evans T-J, Koblar S, Jannes J, Sturm J, et al. Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nat Genet. 2012. doi:10.1038/ng.2397. Second GWAS based gene identification specific to ischaemic stroke with robust replication.

    Google Scholar 

  34. •• Traylor M, Farrall M, Holliday E, Sudlow C, Hopewell J, Cheng Y-C, et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol. 2012;11:951–62. Largest and most powered genetic meta-analysis of GWAS based stroke studies published to date.

    Article  PubMed  Google Scholar 

  35. Williams FMK, Carter AM, Hysi PG, Surdulescu G, Hodgkiss D, Soranzo N, et al. Ischaemic stroke is associated with the ABO locus: The EuroCLOT study. Ann Neurol. 2012;73:16–31.

    Article  Google Scholar 

  36. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex disease. Nature. 2009;461:747–53.

    Article  PubMed  CAS  Google Scholar 

  37. Yang J, Lee S, Goddard M, Visscher P. GCTA: a tool for genome wide complex trait analysis. Am J Hum Genet. 2011;88:76–82.

    Article  PubMed  CAS  Google Scholar 

  38. Bevan S, Traylor M, Adib-Samii P, Malik R, Paul NLM, Jackson C, et al. Genetic heritability of ischaemic stroke and the contribution of previously reported candidate gene and genomewide associations. Stroke. 2012;43:3161–7.

    Article  PubMed  CAS  Google Scholar 

  39. Metzker M. Sequencing technologies - the next generation. Nat Rev Genet. 2010;11:31–46.

    Article  PubMed  CAS  Google Scholar 

  40. Lin B, Clyne M, Walsh M, Gomez O, Yu W, Gwinn M, et al. Tracking the epidemiology of human genes in the literature: the HuGE published literature database. Am J Epidemiol. 2006;164:1–4.

    Article  PubMed  Google Scholar 

  41. Wang L, McLeod HL, Weinshilboum RM. Genomics and drug response. N Eng J Med. 2011;364:1144–53.

    Article  CAS  Google Scholar 

  42. Goodman T, Ferro A, Sharma P. Pharmacogenetics of aspirin resistance: a comprehensive systematic review. BJCP. 2013. doi:10.1111/j.1365-2125.2008.03183.x.

    Google Scholar 

  43. Neubauer H, Kaiser A, Endres H, Kruger J, Engelhardt A, Lask S, et al. Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - the BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy. BMC Med. 2011. doi:10.1186/1741-7015-9-3:3.

    PubMed  Google Scholar 

  44. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348:1329–39.

    Article  Google Scholar 

  45. Diener HC, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA, et al. Effects of aspirin plus extended release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the prevention regimen for effectively avoiding second strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol. 2008;7:875–84.

    Article  PubMed  CAS  Google Scholar 

  46. Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, et al. Cytochrome P450 polymorphisms and response to clopidogrel. N Eng J Med. 2009;360:354–62.

    Article  CAS  Google Scholar 

  47. Sibbing D, Bernlochner I, Kastrati A, Pare G, Eikelboom JW. Current evidence for genetic testing in clopidogrel treated patients undergoing coronary stenting. Circ Cardiovasc Interv. 2011;4:505–13.

    Article  PubMed  Google Scholar 

  48. Pare G, Eikelboom JW, Sibbing D, Bernlochner I, Kastrati A. Testing should not be done in all patients treated with clopidogrel who are undergoing percutaneous coronary intervention. Circ Cardiovasc Interv. 2011;4:514–21.

    Article  PubMed  Google Scholar 

  49. Wysowski DK, Nourjah P, Swartz L. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med. 2007;167:1414–9.

    Article  PubMed  Google Scholar 

  50. Manolopoulos VG, Ragia G, Tavridou A. Pharmacogenetics of coumarinic oral anticoagulants. Pharmacogenomics. 2010;11:493–6.

    Article  PubMed  CAS  Google Scholar 

  51. Ja J, Gong L, Whirl-Carrillo M, Gage BF, Scott SA, Stein CM, et al. Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther. 2011;90:625–9.

    Article  Google Scholar 

Download references

Conflict of Interest

Steve Bevan and Hugh S Markus declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Stroke and Dementia Research Centre, St George’s, University of London, Cranmer Terrace, Tooting, London, SW17 0RE, UK

    Steve Bevan & Hugh S. Markus

Authors
  1. Steve Bevan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hugh S. Markus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hugh S. Markus.

Additional information

This article is part of the Topical Collection on Cardiovascular Disease and Stroke

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bevan, S., Markus, H.S. Genetic Profiles in Ischaemic Stroke. Curr Atheroscler Rep 15, 342 (2013). https://doi.org/10.1007/s11883-013-0342-8

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11883-013-0342-8

Keywords

Search

Navigation